Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort
- DOI
- 10.1016/j.esmoop.2021.100114
- Published
- 2021-06
- Container
- ESMO Open
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2021.100114,
title = {Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort},
author = {T. Grinda and A. Antoine and W. Jacot and C. Blaye and P.-H. Cottu and V. Diéras and F. Dalenc and A. Gonçalves and M. Debled and A. Patsouris and M.-A. Mouret-Reynier and A. Mailliez and F. Clatot and C. Levy and J.-M. Ferrero and I. Desmoulins and L. Uwer and T. Petit and C. Jouannaud and M. Lacroix-Triki and E. Deluche and M. Robain and C. Courtinard and T. Bachelot and E. Brain and D. Pérol and S. Delaloge},
year = {2021},
journal = {ESMO Open},
doi = {10.1016/j.esmoop.2021.100114},
url = {https://doi.org/10.1016/j.esmoop.2021.100114}
}RIS
TY - JOUR TI - Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort AU - T. Grinda AU - A. Antoine AU - W. Jacot AU - C. Blaye AU - P.-H. Cottu AU - V. Diéras AU - F. Dalenc AU - A. Gonçalves AU - M. Debled AU - A. Patsouris AU - M.-A. Mouret-Reynier AU - A. Mailliez AU - F. Clatot AU - C. Levy AU - J.-M. Ferrero AU - I. Desmoulins AU - L. Uwer AU - T. Petit AU - C. Jouannaud AU - M. Lacroix-Triki AU - E. Deluche AU - M. Robain AU - C. Courtinard AU - T. Bachelot AU - E. Brain AU - D. Pérol AU - S. Delaloge PY - 2021 JO - ESMO Open DO - 10.1016/j.esmoop.2021.100114 UR - https://doi.org/10.1016/j.esmoop.2021.100114 ER -
APA
Grinda, T., Antoine, A., Jacot, W., Blaye, C., Cottu, P., Diéras, V., Dalenc, F., Gonçalves, A., Debled, M., Patsouris, A., Mouret-Reynier, M., Mailliez, A., Clatot, F., Levy, C., Ferrero, J., Desmoulins, I., Uwer, L., Petit, T., Jouannaud, C., Lacroix-Triki, M., Deluche, E., Robain, M., Courtinard, C., Bachelot, T., Brain, E., Pérol, D., & Delaloge, S. (2021). Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort. ESMO Open. https://doi.org/10.1016/j.esmoop.2021.100114
Source records
- crossref · retrieved 2026-09-26T14:10:59.249Z